Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?

作者: Cyrus Chargari , Robert Alain Toillon , Dhara MacDermed , Pierre Castadot , Nicolas Magné

DOI: 10.1016/S1470-2045(08)70333-4

关键词:

摘要: … sequencing of hormone and radiotherapy on outcomes in breast cancer, to improve understanding of concurrent … patients with concurrent radiotherapy and hormone therapy to have …

参考文章(71)
Ulrike Hoeller, Kerstin Borgmann, Petra Feyer*, Rainer Souchon*, Zur Interaktion von Strahlentherapie und Tamoxifen beim Mammakarzinom Strahlentherapie Und Onkologie. ,vol. 183, pp. 535- 544 ,(2007) , 10.1007/S00066-007-1710-5
Norman E. Sharpless, Ronald A. DePinho, p53: Good Cop/Bad Cop Cell. ,vol. 110, pp. 9- 12 ,(2002) , 10.1016/S0092-8674(02)00818-8
David Azria, Christel Larbouret, Severine Cunat, Mahmut Ozsahin, Sophie Gourgou, Pierre Martineau, Dean B Evans, Gilles Romieu, Pascal Pujol, Andre Pèlegrin, Letrozole sensitizes breast cancer cells to ionizing radiation Breast Cancer Research. ,vol. 7, pp. 1- 8 ,(2004) , 10.1186/BCR969
Karen Huff, Marc Lippman, Gall Bolan, The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture Cancer Research. ,vol. 36, pp. 4595- 4601 ,(1976)
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer The New England Journal of Medicine. ,vol. 353, pp. 2747- 2757 ,(2005) , 10.1056/NEJMOA052258
Kazuhiro Ikeda, Satoshi Inoue, Estrogen receptors and their downstream targets in cancer. Archives of Histology and Cytology. ,vol. 67, pp. 435- 442 ,(2004) , 10.1679/AOHC.67.435